Keywords: kaletra, impressive, 48-week, hiv, reduction, health, care

Kaletra impressive 48-week HIV reduction

Article | 25 February 2008

Print This

US health care major Abbott Laboratories says that data from a trial of its protease inhibitor Kaletra (lopinavir/ritonavir) indicate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in